Dr. Dream Cold Plazma Whitening
- Manufacturer
- Dr. Dream Inc | New & New Co., Ltd
- Effective date
- 2012-09-25
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:33:07
Label at a glance#
ProductDr. Dream Cold Plazma Whitening
Active ingredientWITCH HAZEL
Label structure8 sections
Label contents#
Full prescribing information#
witch hazel
INACTIVE INGREDIENT SECTION
water, butylene glycol, glycerin, cetyl ethylhexanoate, betaine, olive fruit oil, grape seed oil, polyglyceryl-3 methylglucose distearate, cyclopentasiloxane, beewax, cetyl alcohol, anthemis nobilis flower extract, bentinite, dimethicone, neopentyl glycol diheptanoate, stearyl alcohol, argania spinosa kernel oil, caprylic/crpric triglyceride, grape seed extract, polysorbate 60, dimethicone/vinyl dimethicone crosspolymer, sorbitan stearate, glyceryl stearate, stearic acid, panthenol, peg-100 stearate, synthetic wax peg-10 dimethicone crosspolymer, caprylyl glycol, tocopheryl acetate, torreya nucifera extract, cornus kousa extract, rosa multiflora fruit extract, chloranthus glaber extract, musa basjoo extract, pentylene glycol, palmitoyl oligopeptide, adenosine, isohexadecane, polysorbate 80, disodium edta, dipotassium glycyrrhizate, lavender oil, cymbopogon schoenanthus oil, abies sibirica oil, orange peel oil, amyris balsamifera bark oil, clary oil, lecithin, sodium phosphate, copper tripeptide-1, glycine, glutamine, lysine, leucine, methionine, valine serine, cysteine, cystine, asparagine, alanine, arginine, ornithine, isoleucine, tyrosine, threonine, tryptophan, phenylalanine, proline, histidine
OTC - PURPOSE SECTION
whitening care
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
keep out of reach of the children
INDICATIONS & USAGE SECTION
After applying dream Advanced Facial Treatment Serum, use the built-in spatula to take out the proper amount and apply it to your face as massaging to be well absorbed. There would be better effect if you apply it twice a day in the morning and evening.
WARNINGS SECTION
When using this product
- keep out of eyes, ears, and mouth. If contact occurs, rinse with plenty of cold water right away and contact a physician. If swallowing, drink plenty of water and contact a physician
- keep out of eyes, ears, and mouth. If contact occurs, rinse with plenty of cold water right away and contact a physician. If swallowing, drink plenty of water and contact a physician
DOSAGE & ADMINISTRATION SECTION
for external use only
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 73df98bc-429f-4587-8299-6ad8d52a4f36 | Product name | 2 | 20250304 |
| 2e254488-9fcb-41b3-a7c3-e2c9a3941b29 | Product name | 1 | 20200603 |
| b4ff0805-126a-406d-9cae-fc34fd8e8889 | Product name | 1 | 20190711 |
| d676a241-be05-4740-b3ee-1a5f2ed422d2 | Product name | 4 | 20180615 |
| dd8bd48f-20d6-43c7-b471-3ae872868afa | Product name | 3 | 20180125 |
| d41954ff-bc63-4b2c-aba0-9146707659d7 | Product name | 2 | 20151117 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 1681bc73-b05f-12c3-1075-382ae39f449c | Product name | 1 | 20140508 |
| 64b87b8d-6ae7-cef1-8fd2-34228b0cc1bc | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53077-5001-1 | 2019-11-13 | C162847 | 48780-1 | 97449f38-cf95-f6ea-e053-dbdaa90aa703 | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53077-5001-1 | Dr. Dream Cold Plazma Whitening | 50 mL in 1 BOTTLE, GLASS | CREAM | 50 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53077-5001 | DR. DREAM COLD PLAZMA WHITENING (WITCH HAZEL) CREAM [DR. DREAM INC] | 1 | Legacy NDC, 1 package rows | 20120927_dd664735-5125-4229-96b0-12466f5c8020.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| WITCH HAZEL | ACTIVE INGREDIENT | 101I4J0U34 | 1 | |
| WITCH HAZEL | ACTIVE MOIETY | 101I4J0U34 | 1 | |
| ABIES SIBIRICA LEAF OIL | INACTIVE INGREDIENT | XRY0V4VZKZ | 1 | |
| ACETYL HEXAPEPTIDE-8 | INACTIVE INGREDIENT | L4EL31FWIL | 1 | |
| ADENOSINE | INACTIVE INGREDIENT | K72T3FS567 | 1 | |
| ALANINE | INACTIVE INGREDIENT | OF5P57N2ZX | 1 | |
| AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER | INACTIVE INGREDIENT | W59H9296ZG | 1 | |
| AMYRIS BALSAMIFERA OIL | INACTIVE INGREDIENT | I1BJ961J2E | 1 | |
| ARGININE | INACTIVE INGREDIENT | 94ZLA3W45F | 1 | |
| ASPARAGINE | INACTIVE INGREDIENT | 5Z33R5TKO7 | 1 | |
| BLACK OLIVE | INACTIVE INGREDIENT | 2M6QWV94OC | 1 | |
| CAPRYLHYDROXAMIC ACID | INACTIVE INGREDIENT | UPY805K99W | 1 | |
| CLARY SAGE OIL | INACTIVE INGREDIENT | 87L0D4U3M0 | 1 | |
| CYMBOPOGON SCHOENANTHUS OIL | INACTIVE INGREDIENT | XE7K568ILO | 1 | |
| CYSTEINE | INACTIVE INGREDIENT | K848JZ4886 | 1 | |
| CYSTINE | INACTIVE INGREDIENT | 48TCX9A1VT | 1 | |
| GLUTAMINE | INACTIVE INGREDIENT | 0RH81L854J | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCINE | INACTIVE INGREDIENT | TE7660XO1C | 1 | |
| HISTIDINE | INACTIVE INGREDIENT | 4QD397987E | 1 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| ISOLEUCINE | INACTIVE INGREDIENT | 04Y7590D77 | 1 | |
| LAVANDULA ANGUSTIFOLIA FLOWERING TOP | INACTIVE INGREDIENT | 9YT4B71U8P | 1 | |
| LECITHIN, SOYBEAN | INACTIVE INGREDIENT | 1DI56QDM62 | 1 | |
| LEUCINE | INACTIVE INGREDIENT | GMW67QNF9C | 1 | |
| LYSINE | INACTIVE INGREDIENT | K3Z4F929H6 | 1 | |
| METHIONINE | INACTIVE INGREDIENT | AE28F7PNPL | 1 | |
| MUSA BASJOO WHOLE | INACTIVE INGREDIENT | V3AYC3JL9Y | 1 | |
| NEOPENTYL GLYCOL | INACTIVE INGREDIENT | QI80HXD6S5 | 1 | |
| ORANGE | INACTIVE INGREDIENT | 5EVU04N5QU | 1 | |
| ORNITHINE | INACTIVE INGREDIENT | E524N2IXA3 | 1 | |
| PALMITOYL OLIGOPEPTIDE | INACTIVE INGREDIENT | HO4ZT5S86C | 1 | |
| PALMITOYL PENTAPEPTIDE-4 | INACTIVE INGREDIENT | KK181SM5JG | 1 | |
| PALMITOYL TETRAPEPTIDE-7 | INACTIVE INGREDIENT | Q41S464P1R | 1 | |
| PHENYLALANINE | INACTIVE INGREDIENT | 47E5O17Y3R | 1 | |
| POLYSORBATE 60 | INACTIVE INGREDIENT | CAL22UVI4M | 1 | |
| PREZATIDE COPPER | INACTIVE INGREDIENT | 6BJQ43T1I9 | 1 | |
| PROLINE | INACTIVE INGREDIENT | 9DLQ4CIU6V | 1 | |
| SERINE | INACTIVE INGREDIENT | 452VLY9402 | 1 | |
| SODIUM CHONDROITIN SULFATE (PORCINE; 5500 MW) | INACTIVE INGREDIENT | H5BJH23Z9A | 1 | |
| SODIUM PHOSPHATE | INACTIVE INGREDIENT | SE337SVY37 | 1 | |
| THIOREDOXIN | INACTIVE INGREDIENT | XJZ418133Z | 1 | |
| THREONINE | INACTIVE INGREDIENT | 2ZD004190S | 1 | |
| TRYPTOPHAN | INACTIVE INGREDIENT | 8DUH1N11BX | 1 | |
| TYROSINE | INACTIVE INGREDIENT | 42HK56048U | 1 | |
| VALINE | INACTIVE INGREDIENT | HG18B9YRS7 | 1 |
Products#
Every source-derived product name is available through these pages.
- Dr. Dream Cold Plazma Whitening
- WITCH HAZEL
- MUSA BASJOO WHOLE
- ACETYL HEXAPEPTIDE-8
- PALMITOYL OLIGOPEPTIDE
- PALMITOYL TETRAPEPTIDE-7
- POLYSORBATE 60
- GLYCERIN
- CAPRYLHYDROXAMIC ACID
- ADENOSINE
- AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER
- NEOPENTYL GLYCOL
- BLACK OLIVE
- SODIUM CHONDROITIN SULFATE (PORCINE; 5500 MW)
- LAVANDULA ANGUSTIFOLIA FLOWERING TOP
- CYMBOPOGON SCHOENANTHUS OIL
- ABIES SIBIRICA LEAF OIL
- ORANGE
- AMYRIS BALSAMIFERA OIL
- CLARY SAGE OIL
- LECITHIN, SOYBEAN
- SODIUM PHOSPHATE
- HYALURONATE SODIUM
- THIOREDOXIN
- PREZATIDE COPPER
- PALMITOYL PENTAPEPTIDE-4
- GLYCINE
- GLUTAMINE
- LYSINE
- LEUCINE
- METHIONINE
- VALINE
- SERINE
- CYSTEINE
- CYSTINE
- ASPARAGINE
- ALANINE
- ARGININE
- ORNITHINE
- ISOLEUCINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 53077-5001 | 53077-5001-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 52800 mg | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | INJECTION / INTRADERMAL | 0.2 %w/v | ||
| PROLINE | PROLINE | 9DLQ4CIU6V | INJECTION / INTRAVENOUS | 0.8 %w/v | ||
| LEUCINE | LEUCINE | GMW67QNF9C | INJECTION, SOLUTION / INTRAVENOUS | 0.27 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| HISTIDINE | HISTIDINE | 4QD397987E | INJECTION, SOLUTION / INTRAVENOUS | 0.09 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 6240 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | TABLET, EXTENDED RELEASE / ORAL | 20 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION / INTRAVENOUS | 790 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | TABLET / ORAL | 163.31 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 6240 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | CAPSULE / ORAL | 20 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | TABLET, FILM COATED / ORAL | 0.33 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | SOAP / TOPICAL | 0.21 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| HISTIDINE | HISTIDINE | 4QD397987E | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 63 mg | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | CREAM / TOPICAL | NA | ||
| LYSINE | LYSINE | K3Z4F929H6 | INJECTION, SOLUTION / INTRAVENOUS | 0.22 %w/v | ||
| LEUCINE | LEUCINE | GMW67QNF9C | TABLET / ORAL | 9 mg | ||
| POLYSORBATE 60 | POLYSORBATE 60 | CAL22UVI4M | OINTMENT / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| ISOLEUCINE | ISOLEUCINE | 04Y7590D77 | INJECTION / INTRAVENOUS | 0.9 %w/v | ||
| HYALURONATE SODIUM | SODIUM HYALURONATE | YSE9PPT4TH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 23 mg | ||
| POLYSORBATE 60 | POLYSORBATE 60 | CAL22UVI4M | GUM, CHEWING / BUCCAL | 5 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | INJECTION / INTRABURSAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| HISTIDINE | HISTIDINE | 4QD397987E | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 3.88 mg | ||
| POLYSORBATE 60 | POLYSORBATE 60 | CAL22UVI4M | SUPPOSITORY / RECTAL | 0.05 mg/mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| METHIONINE | METHIONINE | AE28F7PNPL | INJECTION, SOLUTION / INTRAVENOUS | 0.16 %w/v | ||
| GLYCINE | GLYCINE | TE7660XO1C | TABLET, ORALLY DISINTEGRATING / ORAL | 60 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, SOLUTION / INTRAVENOUS | 0.42 %w/v | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | INJECTION, SOLUTION / INTRAVENOUS | 0.14 %w/v | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | SOLUTION / OPHTHALMIC | 0.81 %w/w | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 0.5 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | SOLUTION / ORAL | 27 mg/5ml | ||
| METHIONINE | METHIONINE | AE28F7PNPL | INJECTION / INTRAVENOUS | 16 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | POWDER, FOR SUSPENSION / ORAL | 39 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| METHIONINE | METHIONINE | AE28F7PNPL | TABLET / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | MOUTHWASH / BUCCAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| SODIUM PHOSPHATE | SODIUM PHOSPHATE | SE337SVY37 | INJECTION / INTRAMUSCULAR | 10.6 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCINE | GLYCINE | TE7660XO1C | POWDER / RESPIRATORY (INHALATION) | 2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 336 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2f12c08e-d3b3-48f5-96b1-84ec8c2b3550 | dd664735-5125-4229-96b0-12466f5c8020 | 2012-09-25 | Warnings | 2f12c08e-d3b3-48f5-96b1-84ec8c2b3550 dd664735-5125-4229-96b0-12466f5c8020 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
